Factor VIII - DNARx
Alternative Names: FVIII - DNARxLatest Information Update: 19 Nov 2021
At a glance
- Originator DNARx
- Class Antihaemorrhagics; Blood coagulation factors; Gene therapies; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Haemophilia
Most Recent Events
- 27 Jul 2021 Preclinical trials in Haemophilia in USA (parentral) (DNARx pipeline, July 2021)